Hypocellular Philadelphia chromosome‑positive mixed‑phenotype acute leukemia successfully treated with dasatinib: A case report

Lee,Shin; Fujita,Kei; Wakayama,Hiroto; Kito,Yusuke; Hara,Takeshi; Tsurumi,Hisashi

doi:10.3892/mco.2021.2466

Hypocellular Philadelphia chromosome‑positive mixed‑phenotype acute leukemia successfully treated with dasatinib: A case report

Authors:
- Shin Lee
- Kei Fujita
- Hiroto Wakayama
- Yusuke Kito
- Takeshi Hara
- Hisashi Tsurumi
View Affiliations

Affiliations: Department of Hematology and Oncology, Matsunami General Hospital, Gifu 501‑6062, Japan, Department of Pathology, Matsunami General Hospital, Gifu 501‑6062, Japan
Published online on: December 14, 2021 https://doi.org/10.3892/mco.2021.2466
Article Number: 33

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Both hypocellular leukemia and Philadelphia (Ph) chromosome‑positive mixed‑phenotype acute leukemia (MPAL) are rare subtypes of leukemia showing unfavorable outcomes and lacking established optimal management. Ph‑positive leukemia most often presents with hypercellularity and hypoplasia is a rare condition. The present study reports an extremely rare case of hypocellular biclonal Ph‑positive MPAL, which was diagnosed by biopsy and genetic analysis of bone marrow, and successfully treated with dasatinib and steroids. Briefly, a 77‑year‑old man presented with pancytopenia and flow cytometry of bone marrow could not be evaluated due to hypocellularity. The patient was finally diagnosed with hypocellular Ph‑positive MPAL by genetic analysis and immunostaining of bone marrow biopsy. Although blood cells recovered with methylprednisolone pulse administration alone for concurrent optic neuritis, hematopoietic function rapidly normalized with dasatinib administered after definitive diagnosis of Ph‑positive leukemia. Dasatinib and oral prednisolone were continued following methylprednisolone pulse administration and the patient achieved molecular complete remission (CR) on day 140 of treatment; molecular CR was maintained thereafter without any severe adverse events. In conclusion, the combination of dasatinib and a steroid may be one of the tolerable treatment options for elderly patients with hypocellular biclonal Ph‑positive MPAL. Furthermore, genetic analysis and immunostaining of bone marrow biopsy can help with the diagnosis of leukemia with hypocellular bone marrow.

View Figures

View References

1	Wolach O and Stone RM: Optimal therapeutic strategies for mixed phenotype acute leukemia. Curr Opin Hematol. 27:95–102. 2020.PubMed/NCBI View Article : Google Scholar
2	Weinberg OK and Arber DA: Mixed-phenotype acute leukemia: Historical overview and a new definition. Leukemia. 24:1844–1851. 2010.PubMed/NCBI View Article : Google Scholar
3	Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H and Thiele J (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Vol 2. Revised 4th edition. IARC Publications, Lyon, 2017.
4	Matutes E, Pickl WF, Van't Veer M, Morilla R, Swansbury J, Strobl H, Attarbaschi A, Hopfinger G, Ashley S, Bene MC, et al: Mixed-phenotype acute leukemia: Clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood. 117:3163–3171. 2011.PubMed/NCBI View Article : Google Scholar
5	Weinberg OK, Seetharam M, Ren L, Alizadeh A and Arber DA: Mixed phenotype acute leukemia: A study of 61 cases using World health organization and European Group for the immunological classification of leukaemias criteria. Am J Clin Pathol. 142:803–808. 2014.PubMed/NCBI View Article : Google Scholar
6	Weir EG, Ali Ansari-Lari M, Batista DA, Griffin CA, Fuller S, Smith BD and Borowitz MJ: Acute bilineal leukemia: A rare disease with poor outcome. Leukemia. 21:2264–2270. 2007.PubMed/NCBI View Article : Google Scholar
7	Wang Y, Gu M, Mi Y, Qiu L, Bian S and Wang J: Clinical characteristics and outcomes of mixed phenotype acute leukemia with Philadelphia chromosome positive and/or bcr-abl positive in adult. Int J Hematol. 94:552–555. 2011.PubMed/NCBI View Article : Google Scholar
8	Shimizu H, Yokohama A, Hatsumi N, Takada S, Handa H, Sakura T and Nojima Y: Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era. Eur J Haematol. 93:297–301. 2014.PubMed/NCBI View Article : Google Scholar
9	Park HW, Lee JH, Choi SJ, Lee JH, Seol M, Lee YS, Ryu SG, Kim KH, Jang H, Seo EJ, et al: Hypoplastic acute myeloid leukemia. Blood. 108(4493)2006.
10	Needleman SW, Burns CP, Dick FR and Armitage JO: Hypoplastic acute leukemia. Cancer. 48:1410–1414. 1981.PubMed/NCBI View Article : Google Scholar
11	Berdeaux DH, Glasser L, Serokmann R, Moon T and Durie BG: Hypoplastic acute leukemia: Review of 70 cases with multivariate regression analysis. Hematol Oncol. 4:291–305. 1986.PubMed/NCBI View Article : Google Scholar
12	Killick S, Matutes E, Powles RL, Hamblin M, Swansbury J, Treleaven JG, Zomas A, Atra A and Catovsky D: Outcome of biphenotypic acute leukemia. Haematologica. 84:699–706. 1999.PubMed/NCBI
13	Legrand O, Perrot JY, Simonin G, Baudard M, Cadiou M, Blanc C, Ramond S, Viguié F, Marie JP and Zittoun R: Adult biphenotypic acute leukaemia: An entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Br J Haematol. 100:147–155. 1998.PubMed/NCBI View Article : Google Scholar
14	Heesch S, Neumann M, Schwartz S, Bartram I, Schlee C, Burmeister T, Hänel M, Ganser A, Heuser M, Wendtner CM, et al: Acute leukemias of ambiguous lineage in adults: Molecular and clinical characterization. Ann Hematol. 92:747–758. 2013.PubMed/NCBI View Article : Google Scholar
15	Kawajiri C, Tanaka H, Hashimoto S, Takeda Y, Sakai S, Takagi T, Takeuchi M, Ohwada C, Sakaida E, Shimizu N and Nakaseko C: Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status. Int J Hematol. 99:513–518. 2014.PubMed/NCBI View Article : Google Scholar
16	Takata H, Ikebe T, Sasaki H, Miyazaki Y, Ohtsuka E, Saburi Y, Ogata M and Shirao K: Two elderly patients with philadelphia chromosome positive mixed phenotype acute leukemia who were successfully treated with dasatinib and prednisolone. Intern Med. 55:1177–1181. 2016.PubMed/NCBI View Article : Google Scholar
17	Satake A, Okada M, Asada T, Fujita K, Ikegame K, Tamaki H, Fujimori Y and Ogawa H: Dasatinib is effective against optic nerve infiltration of Philadelphia chromosome-positive acute lymphoblastic leukemia. Leuk Lymphoma. 51:1920–1922. 2010.PubMed/NCBI View Article : Google Scholar
18	Townsend JH, Dubovy SR, Pasol J and Lam BL: Transient optic perineuritis as the initial presentation of central nervous system involvement by pre-B cell lymphocytic leukemia. J Neuroophthalmol. 33:162–164. 2013.PubMed/NCBI View Article : Google Scholar
19	Quann KA and Redner RL: The eyes have it: CNS leukemia presenting as optic neuritis. Int J Hematol. 113:311–312. 2021.PubMed/NCBI View Article : Google Scholar
20	Myers KA, Nikolic A, Romanchuk K, Weis E, Brundler MA, Lafay-Cousin L and Costello F: Optic neuropathy in the context of leukemia or lymphoma: Diagnostic approach to a neuro-oncologic emergency. Neurooncol Pract. 4:60–66. 2017.PubMed/NCBI View Article : Google Scholar
21	Porkka K, Koskenvesa P, Lundán T, Rimpiläinen J, Mustjoki S, Smykla R, Wild R, Luo R, Arnan M, Brethon B, et al: Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia. Blood. 112:1005–1012. 2008.PubMed/NCBI View Article : Google Scholar
22	Gotoh A and Broxmeyer HE: The function of BCR/ABL and related proto-oncogenes. Curr Opin Hematol. 4:3–11. 1997.PubMed/NCBI View Article : Google Scholar
23	Fukunaga A, Sakoda H, Iwamoto Y, Inano S, Sueki Y, Yanagida S and Arima N: Abrupt evolution of Philadelphia chromosome-positive acute myeloid leukemia in myelodysplastic syndrome. Eur J Haematol. 90:245–249. 2013.PubMed/NCBI View Article : Google Scholar
24	Keung YK, Beaty M, Powell BL, Molnar I, Buss D and Pettenati M: Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature. Leuk Res. 28:579–586. 2004.PubMed/NCBI View Article : Google Scholar
25	Islam A: Hypoplastic acute myeloid leukemia in an elderly patient. A long-term partial remission with low-dose prednisone and G-CSF. Clin Case Rep. 7:1285–1290. 2019.PubMed/NCBI View Article : Google Scholar